SCHEMBL30665011

SCHEMBL30665011

c1ccc2c(-c3cnn4cccnc34)ccnc2c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ BMP4 P12644 7/20 1.00
▸ ACVR1 Q04771 12/20 0.55
▸ ACVR1B P36896 11/20 0.55
▸ ACVRL1 P37023 10/20 0.55
▸ BMPR1B O00238 9/20 0.55
▸ BMPR1A P36894 9/20 0.55
▸ KDR P35968 6/20 0.55
▸ TGFBR1 P36897 5/20 0.55
▸ PRKAB1 Q9Y478 5/20 0.55
▸ TGFBR2 P37173 4/20 0.55
▸ JAK1 P23458 1/20 0.54
▸ PIK3C3 Q8NEB9 1/20 0.54
▸ BMPR2 Q13873 3/20 0.51
▸ GRM4 Q14833 1/20 0.50
▸ RIPK2 O43353 1/20 0.50
▸ ACVR2A P27037 1/20 0.50
▸ ACVR2B Q13705 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11953871 1.00 BMP4 (1.00) BMP4ACVR1ACVR1BACVRL1BMPR1B
SCHEMBL30547944 0.91 BMP4 (0.84) BMP4ACVR1ACVR1BACVRL1BMPR1B
SCHEMBL30074621 0.79 BMP4 (0.70) BMP4ACVR1ACVR1BACVRL1BMPR1B
SCHEMBL2059666 0.79 BMP4 (0.70) BMP4ACVR1ACVR1BACVRL1BMPR1B
SCHEMBL11953449 0.78 BMP4 (1.00) BMP4ACVR1ACVR1BACVRL1BMPR1B
SCHEMBL16112179 0.75 BMP4 (0.80) BMP4ACVR1ACVR1BACVRL1BMPR1B
SCHEMBL16112689 0.75 BMP4 (0.68) BMP4ACVR1ACVR1BACVRL1BMPR1B
SCHEMBL1227713 0.75 CYP1A2 (0.60) BMP4TGFBR1TGFBR2GRM4
SCHEMBL29699887 0.75 CYP1A2 (0.60) BMP4TGFBR1TGFBR2GRM4
SCHEMBL27917128 0.75 CYP1A2 (0.60) BMP4TGFBR1TGFBR2GRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4662319-A2 PERSONALIZED CRISPR PROFILING FOR CANCER Integrate Bioscience LLC (US) 2025-12-17 — — EP disclosed
WO-2024168301-A2 PERSONALIZED CRISPR PROFILING FOR CANCER FUNCTION ONCOLOGY, INC. (US) 2024-08-15 — — WO disclosed
US-20230392115-A1 METHODS FOR MAKING AND USING DIFFERENTIATED NEURAL CELLS RESEARCH DEVELOPMENT FOUNDATION (US) 2023-12-07 — — US disclosed
Send feedback